Bunker Hill.png
Bunker Hill Mining Announces Intent to List on the TSX-Venture Exchange
November 11, 2020 07:00 ET | Bunker Hill Mining Corp.
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corporation (the “Company”) (CSE: BNKR) is pleased to report that it has applied to list its shares on the TSX Venture Exchange...
GTI new logo high res.jpg
Green Thumb Industries to Open Rise Kendall, Its 50th Retail Location, on November 18
November 11, 2020 07:00 ET | Green Thumb Industries
CHICAGO and KENDALL, Fla., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of...
Oncorus Updated Logo (002).jpg
Oncorus Reports Third Quarter 2020 Financial Results and Provides Business Highlights
November 11, 2020 07:00 ET | Oncorus, Inc.
-- Received $98.4 million in aggregate gross proceeds in October from initial public offering -- -- Initiated Phase 1 clinical trial of lead viral immunotherapy candidate, ONCR-177, for the...
Tonix2.jpg
Tonix Pharmaceuticals to Participate in Upcoming November Conferences
November 11, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth...
protara_therapeutics@2x.png
Protara Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
November 11, 2020 07:00 ET | Protara Therapeutics
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with...
BioXcelLogo.png
BioXcel Therapeutics Announces Completion of Pre-NDA Meeting with FDA for BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorders
November 11, 2020 07:00 ET | BioXcel Therapeutics
Initiated rolling submission of New Drug Application (“NDA”) with U.S. Food and Drug Administration (“FDA”) On track to submit complete NDA in Q1 2021 NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE...
2020 logo with tagline.png
Anexinet Expands Expert Executive Team with New Executive Vice President and General Manager
November 11, 2020 07:00 ET | Anexinet Corporation
PHILADELPHIA, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Anexinet Corporation, a leading provider of digital business transformation solutions, today announced the appointment of Michael Cirafesi as...
logo.png
TomaGold announces the closing of the transaction with IAMGOLD
November 11, 2020 07:00 ET | TomaGold Corporation
MONTREAL, Nov. 11, 2020 (GLOBE NEWSWIRE) -- TOMAGOLD CORPORATION (TSXV: LOT) (“TomaGold” or the “Corporation”) is pleased to announce that it has closed the transaction (the “Transaction”) with...
Surface Logo New Version-color.png
Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer
November 11, 2020 07:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
ReportLinker logo.jpg
The global electric vehicle market is expected to reach an estimated $335.3 billion by 2023 with a CAGR of 38% from 2018 to 2023
November 11, 2020 06:59 ET | ReportLinker
New York, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Electric Vehicle Market Report: Trends, Forecast and Competitive Analysis" -...